Microbiology Conference | Microbiology Congress | Applied Microbiology Conferences | Infectious Diseases Conference | Antimicrobials Conference | Medical Microbiology Conference | Clinical Microbiology Conference | Pharmaceutical Microbiology Conference | Vienna | Austria | Europe | USA | Middle East

Theme: Innovation in the World of Microbiology and Infectious Diseases

Microbiology Congress 2021

Microbiology Congress 2021

The 9th Global Summit on Microbiology and Infectious Diseases 2021 will be held on November 08-09, 2021 in Vienna, Austria. Microbiology Congress 2021 is thrilled to welcome scientists, researchers, professors and delegates from all over the world to the upcoming Microbiology and Infectious Diseases Conference, which will focus on "New Trends in Microbiology and Infectious Diseases"

Microbiology Congress 2021 hosts global events each year, including conferences, workshops and symposiums in the United States, Europe and Asia-Pacific with the help of scientific societies and has already published open access journals with eminent and reputed scientists as authors.

At the Conference, a Student Poster Competition is held to inspire students and recent graduates to present their original research, which will then be published in one of our supporting international journals. Both approved abstracts will be discussed at the conference's poster sessions. For all students who are unable to attend the conference, the Conference Series offers an opportunity to display an E-Poster.

Business networking provides vendors with a platform for networking and B2B meetings with Top scientists and colleagues as well as a low-cost marketing tool for creating sales, opportunities and contacts, based on referrals and introductions made face-to-face at meetings and conferences or through other communication methods such as telephone, email, digital and increasingly social and business media.

Opportunities for Researchers and Professors

Presentations by Speakers
Display of Posters
Hosting a symposium (4-5 member team)
Organizing workshop
Universities, Societies and Associations
Proposals for collaboration between associations
Participation in Academic Partnering Groups

For Students and Scholars in Research

Competition for Posters (Winner will get Best Poster Award)
Forum for Young Researchers (YRF Award to the best presenter)
Registrations for Student Attendee Groups.

Delegates from the business world

Presentations by Speakers
The symposium will host a book launch celebration, which will provide networking opportunities.
Participation of the audience

Manufacturers of Products

Booths for exhibitors and vendors
Opportunities for sponsorship
Scientific Partnering Workshops are being organised in preparation for the launch of a new product.
Networking with clients and marketing.

SESSION-1: Antibiotic effectiveness is driven by interactions between the microbiome and the diet.

By altering surface-exposed antigens, such as O-antigens, certain gut bacterial pathogens can evade antibody-mediated defence. However, viruses can be guided to evolve towards producing O-antigen variants that impede gut colonisation by employing vaccines that target particular O-antigens to stimulate immunoglobulin A responses in the gut.

Related Societies

SESSION-2:Antibiotic effectiveness is driven by interactions between the microbiome and the diet.

In a mouse model, a high-fat diet promotes dysbios is of the gut microbiota and depletion of the microbial metabolite indole-3-acetic acid, resulting in reduced antibiotic effectiveness against bacterial infections.

SESSION-3: Microbial Enzymes

Enzymes are thought to be a potential biocatalyst for a wide range of reactions. Microbial enzymes, in particular, have numerous applications in industry and medicine. Additionally, microbial enzymes are more active and stable than plant and animal enzymes. Furthermore, because of their biochemical diversity and susceptibility to gene manipulation, microorganisms represent an alternative source of enzymes because they can be cultured in large quantities in a short period of time via fermentation.

Microbiome,Probiotics and Gut Nutrition | Prasaitology and Microbes | Applied Microbiology And Beneficial Microbes | Cell and Tissue

SESSION-4: Microbial Biofilms

Aggregate of microorganisms in which cells adhere to each other and/or to a surface and are frequently embedded within a self-produced matrix of extracellular polymeric substance (EPS). A biofilm is a system whose inhabitants can adapt internally to environmental conditions. Slime, or self-produced extracellular polymeric material, is a polymeric conglomeration made up of extracellular biopolymers in various structural types.

Microbiology and Clinical research | Applied Microbiology | Parasitology and Infectious diseases | Virology Summit | Medical and Clinical Microbiology

SESSION-5: Marine Microbiology

Microorganisms (bacteria, archaea, viruses, and microbial eukaryotes) in the aquatic world, including their biodiversity, ecology, and biogeochemistry, are studied in marine microbiology. The use of metagenomics in revealing the abundance and composition of marine microbial ecosystems has been crucial.

Prasaitology and Microbes | Applied Microbiology And Beneficial Microbes | Antimicrobial Agents Conferences | Antimicrobial Resistance Conferences | Antimicrobial Agents Events

SESSION-6: Public Health Microbiology and Emerging Infectious Diseases

Microbial pathogenesis, public health principles, epidemiology, molecular genetics, virology, and environmental and industrial microbial processes are all included in the Public Health and Microbiology concentration. This concentration prepares students for technical work or graduate school in microbial disease systems using polymerase chain reaction and other molecular diagnostic methods, as well as environmental and industrial applications of microbial systems.

Clinical Microbiology Conferences | Applied Microbiology Conferences | Medical Microbiology Meetings | Antimicrobial Agents Conferences

SESSION-7: Pharmaceutical Microbiology

Pharmaceutical Microbiology deals with the study of microorganisms that is concerned within the manufacture of prescribed drugs. Alternative aspects of pharmaceutical biological science embrace the analysis and development of anti-infective agents, the use of microorganisms in the production of pharmaceutical products such as endocrine and human human growth hormone, and hence the use of microorganisms in the production of pharmaceutical products such as endocrine and human human growth hormone.

SESSION-8: Antimicrobial Agents and Infectious diseases

Antimicrobials are chemicals that destroy or prevent the growth of bacteria, viruses, fungi, and parasites. They are classified as antibacterials, antivirals, antifungals, and antiparasitics. Antibacterials are used to treat bacterial infections, antivirals are used t o treat viruses, and antifungals and antiparasitics are used to treat fungi and parasites, respectively.

Applied Microbiology And Beneficial Microbes | Antimicrobial Agents Conferences | Antimicrobial Resistance Conferences | Prasaitology and Microbes | Applied Microbiology And Beneficial Microbes

SESSION-9: Agricultural Microbiology

Plant-associated microbes are the subject of agricultural microbiology research. Its aim is to solve issues in agricultural practises that are typically caused by a lack of biodiversity in microbial communities. Understanding microbial strains that are important to agricultural applications can help improve things like soil nutrients, plant-pathogen tolerance, crop robustness.

SESSION-10: Infection and Immunity

Immunology is a branch of science that studies the immune system, including both innate and acquired immunity, as well as laboratory techniques involving the interaction of antigens with particular antibodies. Microbiology is a branch of science that studies different microorganisms. Microbiology is the study of bacteria's structure and various physical, chemical, and biological characteristics that relate to their disease-causing potential.

SESSION-11: Pathogenicity of Microbes

The tendency of an organism to cause disease is referred to as pathogenicity (ie, harm the host). The overt damage done to the host is a property of the host-pathogen relationships, and this capacity represents a genetic component of the pathogen. This innate propensity to inflict disease is absent in commensals and opportunistic pathogens. Disease is not, however, an unavoidable result of the host-pathogen relationship.

SESSION-12: Microbiology Research and Advancements

Infections caused by bacteria, viruses, fungi, mycobacteria, and parasites can all be treated through rapid detection of microorganisms in clinical microbiology. Rapid detection of microorganisms in clinical samples allows for a more rapid switch from broad-spectrum to tailored antimicrobial therapy.

SESSION-13: Microbiomes

The microbiome is the genetic material of all microbes that exist on and within the human body, including bacteria, fungi, protozoa, and viruses. The total number of genes in a person's microbiome is 200 times greater than the number of genes in the human genome. It's possible that the microbiota weighs up to five pounds.

SESSION-14: Biotechnology & Synthetic Biology

Synthetic biology is a form of biotechnology that involves the development of Synthetic biotechnology includes the manipulation of biological compounds including incorporation of synthetic aminoacids into proteins, DNA synthesis and manipulation using synthetic sequences, oligonucleotide synthesis, protein alteration using synthetic compounds etc.

SESSION-15: Environmental Microbiology

The study of the structure and physiology of microbial communities in the atmosphere is known as environmental microbiology. The study of microorganisms in the atmosphere has been revolutionised by molecular biology, which has enhanced our understanding of the structure, phylogeny, and physiology of microbial species. The scientific study of microorganisms in the atmosphere is known as environmental microbiology. Air microbiology, soil microbiology, and water microbiology are all part of this field.

SESSION-16: Microbiology major Research thematic areas

Detection and diagnosis of microbes: Identification, characterization, data base and storage facilities development for microbial culture collection. Food spoilage and Foodborne pathogenic microbes. Mycotoxigenic fungi and other toxin producing microbes. Beneficial microbes. Establishment of database and storage facilities for microbial culture collections

Related Society

Market Research

Market research is vital to the development of the industrial market, and continues to be in demand. In 2021, we anticipate delivery of new editions of our report on Microbiology Testing in the Global spurt.

Global Market Survey

Microbiology was about more than USD 24.3 billion in 2017 and will be worth as much as USD 675.2 billion by 2024, with a 7.9% CAGR. With a compound annual growth rate (CAGR) of 8.1 percent compared to 2017 to 2025, this market is forecast to expand to approximately $9.6 billion in 2017 and $15.7 billion by 2025.

The clinical microbiology market has been influenced by the COVID-19 pandemic. Manufacturing and supply chain hurdles confront the field, including timely delivery of goods to end-users and meeting inconsistent demand for the sector's products and services.Furthermore, a limited availability of skilled lab professionals to conduct/study diagnostic tests, limited operations in most industries, completely inadequate funding for research and academic institutes, the temporary closure of major academic institutes, a disrupted supply chain, and challenges in providing essential/post-sales services due to lockdowns have all caused a drop in clinical microbiology product supply.

The global DNA sequencing market is projected to reach USD 85.5 Million by 2025 from USD 310.1 Million in 2017 growing at a CAGR of 8.5% during the forecast period. The global market for Food Microbiology reached nearly $7.1 billion in 2017. This market is expected to grow to nearly $9.6 billion in 2017 and $15.7 billion by 2025, with a compound annual growth rate (CAGR) of 8.1% from 2017 to 2025.

Product

Based on technology, the industry is segmented into tissue engineering and regeneration, fermentation, PCR, nanotechnology, chromatography, DNA sequencing and cell based assay. In 2021, the tissue engineering and regeneration segment accounted for highest revenue and was valued at over USD 11.3 billion. However, the nanotechnology, fermentation and cell based assay segments will experience lucrative growth owing to rising R&D initiatives by various biotechnological and pharmaceutical companies.

The global microbiology market is valued at $6,727.29 million in 2014 and is expected to grow at a CAGR of 13.03% between 2014 and 2021. Increasing disease burden of infectious diseases and increased funding for healthcare expenditure are the important growth drivers for this market during the forecast period. The pharmaceuticals application segment accounted for the largest share of the microbiology market in 2014, while the food application segment is expected grow at the highest CAGR between 2014 and 2021 in the global microbiology market.

Market Overview

Billion in 2020, the market is expected to increase at a compound annual growth rate (CAGR) of 6.8% from 2020 to 2027, reaching a revised size of US$6.2 billion. Instruments, one of the report's segments, is expected to grow at a CAGR of 6.4 percent and reach US$2.5 billion by the conclusion of the research period.Following an eye examination of the pandemic's commercial repercussions and the resulting economic crisis, the Reagents & Kits segment's growth is revised to a revised 7.4% CAGR for the life of the agreement.

The economy in the United States is supposed to be worth $1.1 billion, while China is expected to grow at a rate of 10.4 percent each year - In the United States, the market for rapid microbiology testing is estimated at us$1.1 billion by 2020. China, the world ’s second - largest economy, is anticipated to raise a projected market size of US$1.3 billion by 2027, with a CAGR of 10.3 percent between 2020 and 2027.Japan and Canada are two additional significant geographic markets, with forecasted growth rates of 3.7 percent and 6.2 percent, respectively, from 2020 to 2027. Germany is expected to develop at a CAGR of around 4.4 percent in Europe.

Industry Insights

The global microbiology market size was valued at USD 9.1 billion in 2016 and is expected to develop at a CAGR of 6.7% over the forecast period. Constantly rising incidence of infectious diseases is driving market growth. Infectious diseases are primarily diagnosed using clinical tests. According to the Centres for Disease Control and Prevention (CDC), around 9,421 new cases of tuberculosis, 51,455 new cases of salmonella, 33,461 new cases of Lyme disease, and 433 new cases of meningococcal disease were registered in U.S. in 2021

Similarly, according to the American Cancer Society, around 1,688,780 new cases of cancer were diagnosed in U.S. in 2017. Thus, high prevalence of diseases where clinical tests are used as one of the major diagnostic tools is expected to augment market growth in future. Sudden outbreaks of Ebola, Zika and other contagious pathogens are also contributing to rising prevalence of infectious diseases. As per an article published in the Journal of Clinical Microbiology, there is a shortage of trained and skilled professionals in medical and microbiological laboratories for processing and interpreting samples and specimens. Moreover, there has been a steep decline in the number of medical laboratory training programs and students graduating from such programs in U.S.

Report Coverage & Deliverables

• Competitive benchmarking
• Market forecasts
• Company market shares
• Market opportunities
• Latest trends & dynamics

Product Insights

Reagents accounted for the largest revenue share in the global microbiology market. The segment includes products such as solutions, primers, master mixes, and kits used in various diagnostic assays. Reagents currently captures the largest revenue share, with more than 60% attributed to repeat purchase driven by need for new set of reagents for new tests.

The segment is expected to remain dominant throughout the forecast period. Factors such as higher cost of specialized kits and constant repeat purchase are expected to drive the segment over the forecast period. The market is witnessing rising. Investments in research and development (R&D). Almost all analytical and therapeutic research projects demand reagents and chemicals, thereby driving penetration of reagents..

Application Insights

Increasing levels of air pollution with growing industrialization is resulting in rapid escalation in prevalence of respiratory diseases. Also, among all infections, respiratory diseases spread rapidly owing to easy transfer of contagious pathogens. Thus, the segment is expected to show significant growth over the forecast period. Furthermore, prevalence of infectious diseases is high in developed as well as developing countries.

Clinical Microbiology 2016 Report

The 6th Clinical Microbiology Conference hosted by the Conferenceseries LLC Group was held duringOctober 20-22, 2016 Rome, Italy with the theme “One Health: To attain optimal health for people, animals and the environment".with topics exploring risks and best practices in infectious disease.

The Conference was accomplished by the support of top microbial experts, diagnostic therapists, physicians, bacteriologists, laboratory scientists, industry researchers, scholars, decision makers, public health professionals and other health care professionals around the world and exchanged ideas on new therapeutic approaches, recommendations and latest clinical data. The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

Microbial Pathogenesis

Nosocomial Infections

Epidemiology

Parasitic Diseases

Disease Diagnosis and Prevention

Fungal Diseases

Viral Infections

Antimicrobial Agents

Bacterial diseases

Dynamics and consequences of antimicrobial resistance

Microbial Biochemistry

Infection Control

Infectious diseases

Health Science

Medical Microbiology

Host Pathogen Interactions

Antimicrobials and Chemotherapy

Immunity and Vaccination

Microbial Biofilms

Conferenceseries LLC Group International would like to convey a warm gratitude to all the Honourable guests and Keynote Speakers of Clinical Microbiology 2016:

Clinical Microbiology-2016 Organizing Committee would like to thank Moderators of the conference

Clinical Microbiology-2016 was moderated by Dr. Rossella Colomba Lelli, Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise “G. Caporale”, Italy

We are thankful to our below Honourable guests and Keynote Speakers for their generous support and suggestions.

Amy C Sims - University of North Carolina at Chapel Hill, USA

Giulio Tarro – T. & L. de Beaumont Bonelli for cancer research, Italy

Daniela Maria Cirillo - San Raffaele Scientific Institute Milan, Italy

Claudio Galli - Abbott Diagnostics, Italy

Nicholas Bergman - National Bioforensic Analysis Center, USA

Nicola Petrosillo – National Institute for Infectious Diseases, Italy

Maria Rita Castrucci - WHO National Influenza Centre, Italy

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following topics were highlighted as Keynote-presentations:

The small molecule nucleoside prodrug GS-5734 exhibits broad antiviral activity against pathogenic human coronaviruses and related zoonotic strains : Amy C Sims, University of North Carolina at Chapel Hill, USA

Human vaccines for infectious and non-infectious diseases: Giulio Tarro, T. & L. de Beaumont Bonelli for cancer research, Italy

Turning WGS-based diagnostics into practice for diagnosis of drug resistant tuberculosis : Daniela Maria Cirillo , San Raffaele Scientific Institute Milan, Italy

New insights in the diagnosis and monitoring of HCV infection : Claudio Galli, Abbott Diagnostics, Italy

Genomics-based bioforensic analysis at the national bioforensic analysis center: Nicholas Bergman, National Bioforensic Analysis Center, USA

Clostridium difficile infection in the healthcare setting : Nicola Petrosillo, National Institute for Infectious Diseases, Italy

Virological surveillance of the continuously evolving influenza viruses : Maria Rita Castrucci, WHO National Influenza Centre, Italy

International also took the privilege of felicitating Clinical Microbiology-2016, Chair and Co-Chairs whose support made conference a great success.

Various sessions were chaired and co chaired by:

Maurizio Provenzano, University Hospital Zurich, Switzerland, Fiona McPhee, Bristol-Myers Squibb Co, USA, Gianfranco Donelli, Microbial Biofilm Laboratory, Italy, Charles William Keevil, University of Southampton Centre for Biological Sciences, UK, Margitta Dathe, Leibniz Institute of Molecular Pharmacology, Germany, Charles William Keevil, University of Southampton Centre for Biological Sciences, UK, Margitta Dathe, Leibniz Institute of Molecular Pharmacology, Germany, Zhiheng Pei, New York University School of Medicine, USA, Liying Yang, New York University School of Medicine, USA, Wolfgang R.Heizmann, University of Tübingen, Germany, Amaresh Das, APHIS-USDA, USA

Our Best Poster Presentation is:

Title: Bovine mastitis: Staphylococci and resistance genes towards β-lactams and macrolides-lincosamides antibiotics in Argentina, Mariela E rednik, University of Buenos Aires, Argentina

Title: Antibacterial Activity of N-Styryl alkylimidazolium Ionic Liquids, Luis Guzman J, Universidad de Talca, Chile

Our special thanks to the editors of Clinical Microbiology: Open Access, Journal of Microbial and Biochemical Technology, Journal of Medical Microbiology & Diagnosisand the organizing committee members, Chair and Co-Chairs for their immense support and beneficial approach.

The conference proceedings were carried out through various Scientific-sessions and plenary lectures.

ConferenceSeries LLC Group Conferences is glad to announce “8^th Clinical Microbiology Conference” scheduled from October 26-27, 2017 Paris, France, the only meeting in the field that offers you the rare opportunity to explore the complete spectrum of microbiology - from basic science to translational and clinical application.

Clinical Microbiology-2017 is guaranteed to offer something best of interest. Bookmark your dates now.

For more details: http://clinicalmicrobiology.conferenceseries.com/

Visa application Documents

For conference attendance and participation only Business Visa should be applied. Contact your nearest travel agent/visa information center/ Amsterdam, Netherlands Embassy for the correct application form.

All visas for visiting / Amsterdam, Netherlands shall be processed by respective authorities only upon submission of proper documents through proper channel.

In case of non-furnishing of documents, non-adherence to guidelines visas shall be cancelled by respective authorities.

The minimum supportive documents that might be required while applying for / Amsterdam, Netherlands visa include:

Letter of invitation,

Abstract acceptance letter (if speaker),

Registration payment receipt,

Accommodation confirmation letter issued under conference letter head.

For letter of invitation and accommodation confirmation, payment of registration fees and accommodation charges is a pre-requisite.

Visa application Documents

All visas for visiting / Amsterdam, Netherlands shall be processed by respective authorities only upon submission of proper documents through proper channel.

In case of non-furnishing of documents, non-adherence to guidelines visas shall be cancelled by respective authorities.

The minimum supportive documents that might be required while applying for / Amsterdam, Netherlands visa include:

Letter of invitation,

Abstract acceptance letter (if speaker),

Registration payment receipt,

Accommodation confirmation letter issued under conference letter head.

For letter of invitation and accommodation confirmation, payment of registration fees and accommodation charges is a pre-requisite.

Participation Options and Benefits

PARTICIPATION OPTIONS: MICROBIOLOGY CONGRESS 2021, provides the participants with different modes or ways to participate such as Delegate or Speaker under either ACADEMIC / STUDENT / BUSINESS Category.

Keynote speaker: 45-50 minutes
Speaker (oral presentation): 25-30 minutes (only one person can present)
Speaker (workshop): 45-50 minutes (more than 1 can present)
Speaker (special session): 45-50 minutes (more than 1 can present)
Speaker (symposium): more than 45 minutes (more than 1 can present)
Delegate(only registration): will have access to all the sessions with all the benefits of registration
Poster presenter: can present a poster and enjoy the benefits of delegate
Remote attendance: can participate via video presentation or e-poster presentation
Exhibitor: can exhibit his/her company’s products by booking exhibitor booths of different sizes
Media partner
Sponsor
Collaborator

For more details about each mode, kindly contact: mailto:microbiology@meetingsemail.com

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	November 08-09, 2021
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1
Poster Opportunity Closed	Click Here to View

Media Partners

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

9^th World Congress on Microbiology & Infectious Diseases November 08-09, 2021 Vienna, Austria

Recommended Global Medical Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links